Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
| Autor: | Dreyling, Martin, Jurczak, Wojciech, Jerkeman, Mats, Silva, Rodrigo Santucci, Rusconi, Chiara, Trneny, Marek, Offner, Fritz, Caballero, Dolores, Joao, Cristina, Witzens-Harig, Mathias, Hess, Georg, Bence-Bruckler, Isabelle, Cho, Seok-Goo, Bothos, John, Goldberg, Jenna D, Enny, Christopher, Traina, Shana, Balasubramanian, Sriram, Bandyopadhyay, Nibedita, Sun, Steven, Vermeulen, Jessica, Rizo, Aleksandra, Rule, Simon |
|---|---|
| Zdroj: | In The Lancet 20-26 February 2016 387(10020):770-778 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|